CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » Gastrointestinal Cancers » Colorectal Cancer

RESEARCH REPORT 

Switch to 5-Year Follow-Up Could Still Prevent Colorectal Cancer Even After High-Risk Polyp Removal

Authors stress need for more initial screening

By Anna Azvolinsky, PhD1 | August 24, 2012
1Freelance Science Writer and CancerNetwork Contributor. Follow Her on Twitter

Researchers in Germany have assessed the risk of colorectal cancer (CRC) among patients who had an adenoma detected and removed, finding longer-term follow-up would still lower risk of CRC development. The population based case-control study is published in the Journal of Clinical Oncology.

Adenomatous polyp with long pedicle

“Risk of CRC was strongly and significantly reduced even between 3 and 5 years after detection and removal of high-risk adenomas,” according to Hermann Brenner, MD, of the University of Heidelberg in Heidelberg, Germany and coauthors. “Strong, significant risk reduction within 5 years after colonoscopic polypectomy was consistently seen among both women and men, and among both younger (less than 70 years) and older (greater than 70 years) patients.” This assessment included both patients with and without a previous history of CRC.

The study suggests that the low risk of detecting CRC within a 3-year time period can be extended to 5 years after a patient has had a polypectomy—even if the polyp removed was a high-risk adenoma.

While observational evidence suggests patients who had an adenoma removed from their colon during a colonoscopy may be more at risk for recurrence, studies assessing the risk of CRC after polyp removal is scarce. Colonoscopies are recommended as a primary screening tool but an outstanding question is the time to next surveillance for those patients who have had a polyp removed. In the United States, the current guidelines, updated in 2006, suggest those patients with a low-risk polyp need to be rescreened within 5 to 10 years, while those with a high-risk polyp should be followed up after 3 years. These recommendations are based on subsequent polyp, not CRC recurrence. The authors of the current study highlight overuse of colonoscopy screening for patients with a history of low-risk polyps, and underuse in patients with a history of high-risk polyps. Defining surveillance windows is important because as many as 30% of patients have a polyp removed upon their first colonoscopy.

Study Design and Results

All patients were from Germany, and their previous records of large-bowel endoscopies were reviewed. In total 2,582 patients with a history of CRC and 1,789 controls were analyzed in the study. Most participants were between 60 and 79 of age—the median age was 69 among patients, and 70 among the control group;160 patients and 264 controls had polyps detected and removed within the last 10 years of analysis. The typical patient who had a polyp removed was older and male compared to the study participants who had no polyps detected.

Those participants who had a colonoscopy within the last 5 years had a strongly reduced risk of CRC compared to participants with no previous colonoscopy. Relative risk reduction was 80% for participants who had had a polypectomy within a 3-year time period and 60% for those who had a polypectomy within a 3- to 5-year time period. Those patients who last had a colonoscopy 6 to 10 years ago had the same risk as participants who had no previous history of a colonoscopy.

When patients with a previous history of CRC were excluded, there was a risk reduction for those who had a polypectomy within 5 years, but it was not statistically significant compared to patients who went longer than 5 years between colonoscopies. There was a strong risk reduction for patients who had a colonoscopy within 5 years of a previous polypectomy that removed a high-risk polyp. Relative risk reduction was 60% for a subsequent colonoscopy within 3 years of the previous one, and 50% if the colonoscopy was within 5 years of the previous procedure.

The authors state that because they observed a similar risk of detecting a new polyp in the 3-year and 5-year time frame, the results challenge the “common understanding that a surveillance interval of 3 years is needed after detection and removal of high-risk adenomas, which is mainly based on studies that focused on risk of advanced adenomas following colonoscopic polypectomy.” Because most advanced adenomas progress slowly to CRC, extension of surveillance to a 5-year time frame is plausible. The authors highlight that while there is a low risk of CRC after polyp removal within a 5-year time frame, the risk returns beyond 5 years, even following a negative colonoscopy, likely due to an inherited risk component.

Overall, the authors propose that a shift toward more first-time colonoscopies is needed, and surveillance for those who have had a previous colonoscopy—even if a high-risk polyp was removed—could be extended to a 5-year interval. The time to subsequent colonoscopy could even be extended further for those who had a low-risk polyp or negative colonoscopy.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.






 
RELATED CONTENT

Axitinib Fails to Improve Survival in Metastatic Colorectal Cancer
May 6, 2013
A 47-Year-Old Patient With Chronic Abdominal Pain
April 26, 2013
Endometrial Cancer at Young Age Ups Risk for Colorectal Cancer
April 22, 2013
Smoking Linked to Poorer Prognosis in Colon Cancer
April 13, 2013
Colorectal Lesions
March 8, 2013
 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
   SEARCH MEDICA RX
   Browse drugs by name:
A B C D E F G H I J
K L M N O P Q R S T
U V W X Y Z All      
   Search for drugs:
Search

 

 
FROM PHYSICIANS PRACTICE
Primary Care Can't Thrive Without Nurse Practitioners
Courtney H. Lyder, ND,  May 17, 2013
With a projected shortfall of primary-care physicians, it's time for alternate solutions to patient care. Nurse practitioners are one logical remedy.
VWhat Physicians Can Learn from the Allscripts EHR Lawsuit
Marisa Torrieri,  May 16, 2013
Lawsuit prompts question: What should physicians do to ensure they end up with a great EHR instead of buyer’s remorse?
Eight Ways ICD-9 Will Still Matter to Medical Practices
Brenda Edwards, CPC,  May 15, 2013
What should your medical practice do with your ICD-9-CM book after October 1, 2014? Keep it.
Seven Ways Technology Can Speed Up Patient Collections
Cheyenne Brinson,  May 15, 2013
Failing to adopt widely available billing and collections technology can cost medical practices big. Here's how to do it right.
Four Reasons Private Medical Practice is Becoming Extinct
Carol Stryker,  May 15, 2013
It’s becoming increasingly difficult for private medical practices to thrive. Here’s what’s driving the trend toward consolidation.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Skin Lesions
  • Colorectal Lesions
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • ONS: Understanding Spirituality and How It Can Be Used to Help Patients
  • Colorectal Lesions
  • New AUA Guidelines for Prostate Cancer Screening
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • Genomics Studies Identify Testicular Cancer Risk Variants
  • Lower Back Pain in an Elderly Man With a History of Localized Prostate Cancer
  • FDA Approves Erlotinib (Tarceva) as First-Line Lung Cancer Therapy for Certain Patients
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • “This Is My Last Day on Earth”
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Patient Quality of Life Endpoints in Oncology Trials, Part II
  • Who's Coding Whom?
  • “How Do I Say This Nicely? Your Oncologist Wasn't Following Guidelines”
  • Study: Cholesterol Drugs Reduced Risk of Prostate Cancer Death
  • “This Is My Last Day on Earth”
  • ONS: Safe Handling of Chemotherapy
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Conflicts of Interest in Medicine: What About Ties to Payers?
Click here to subscribe to our newsletter


 
SEARCH MEDICA SEARCH RESULT

Find peer-reviewed literature and websites for practicing medical professionals

CME on Colorectal Cancer
Evidence on Colorectal Cancer
Guidelines on Colorectal Cancer
Patient Education on Colorectal Cancer
Clinical Trials on Colorectal Cancer
Practical Articles on Colorectal Cancer
Research and Reviews on Colorectal Cancer
All "Colorectal Cancer" results


CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy